Internationalism No. 86, April 2026 Page 7 From the series Industry and pharmaceuticals I Since the beginning of the 21 st century, the life sciences sector has undergone profound transformations. Great scientific and technological innovations rooted in the achievements of the 20 th century have affected the whole of the world's healthcare system, revolutionising diagnostic procedures and therapies. However, the fruits of this acceleration of scientific development only reach a minority of humanity. In many cases, the high costs and the limited number of adequate structures — think of gene and cell therapies — make them inaccessible to most of the population, which barely receives even the most basic and lifesaving medicines. Their economic sustainability is a challenge even for the more advanced healthcare and welfare systems. Biotechnology is at the heart of this transformation, which is reshaping the world industry of...